FindTrial
Sign In

Varicella Virus Vaccine Live

BIOLOGICAL3 trials

Sponsors

Sanofi Pasteur, a Sanofi Company

Conditions

Diphtheria ImmunisationHaemophilus Influenzae Type b ImmunisationHealthy Volunteers (Meningococcal Infection)Hepatitis B ImmunisationMeasles ImmunisationMeningitisMeningococcal InfectionMumps Immunisation

Phase 2

A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers
CompletedNCT01049035
Sanofi Pasteur, a Sanofi CompanyMeningitis, Meningococcal Infection
Start: 2009-12-16End: 2012-02-13Updated: 2022-03-28
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants
CompletedNCT04398706
Sanofi Pasteur, a Sanofi CompanyDiphtheria Immunisation, Haemophilus Influenzae Type b Immunisation, Hepatitis B Immunisation +8
Start: 2020-05-22End: 2023-08-10Updated: 2025-09-08

Phase 3

Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
CompletedNCT03691610
Sanofi Pasteur, a Sanofi CompanyHealthy Volunteers (Meningococcal Infection)
Start: 2018-10-04End: 2023-10-20Updated: 2024-06-25

Related Papers

Meningococcal quadrivalent ACYW-TT conjugated vaccine at 6–23 months: phase III study (US/Puerto Rico)
Pediatric Research2026-03-06
P-662. Phase III, modified double-blind, randomized, parallel group, active-controlled, multi-center study of Meningococcal quadrivalent ACWY conjugated vaccine in infants from 6 through 23 months of age in the United States
Open Forum Infectious Diseases2025-01-29
Safety and immunogenicity of an investigational quadrivalent meningococcal tetanus toxoid conjugate vaccine (MenACYW-TT) co-administered with routine pediatric vaccines in infants and toddlers: A Phase II study
Vaccine2022-02-075 citations